Introduction: Ovarian cancer is the leading cause of death from gynecologic cancers, in
fact,> 80% of cases are diagnosed as advanced-stage disease associated with a high …

Background Despite a myriad of attempts in the last three decades to diagnose ovarian
cancer (OC) earlier, this clinical aim still remains a significant challenge. Aberrant …

Introduction: Ovarian cancer (OC) is one of the leading causes of cancer-related death in
women. Accumulating evidence showed an evolving role of HE4 in monitoring the …

Background Chemotherapy resistance presents a difficult challenge in treating epithelial
ovarian cancer patients, particularly when tumors exhibit resistance to multiple …

Objectives To assess the clinical value of early clearance of HE4 and CA125 for platinum
sensitivity and prognosis in patients with ovarian cancer. Method HE4 and CA125 value …

Overexpression of Human epididymis protein 4 (HE4) related with a role in ovarian cancer
tumorigenesis while little is known about the molecular mechanism alteration by HE4 up …

Aim Human epididymis protein 4 (HE4) is a novel biomarker for epithelial ovarian cancer.
This study was designed to evaluate the role of HE4 in chemo‐response against anti‐cancer …

Epithelial ovarian cancer (EOC) remains the deadliest form of gynecological cancers.
Optimal tumor debulking, no matter the primary or the interval, is the most important …

Objective To evaluate the predictive potential of total metabolic tumor volume (MTV)
reduction during neoadjuvant chemotherapy (NACT) with 18 F–FDG-PET/CT in an …

Objective The aim of this study was to examine the relationship between the reduction of
maximum standardized uptake values (SUVmax) in 18 F-FDG-PET/CT to histopathological …